L-685,458 and puromycin were purchased from Sigma. β-Actin antibody (1:10,000) was purchased from Sigma. The APP C-terminal antibody (A8717; 1:1,000) was purchased from Sigma. The ubiquilin-1 antibody (1:160) was purchased from Zymed. The HRP-conjugated secondary antibodies (anti-mouse and anti-rabbit) (1:10,000) were purchased from GE. The plasmids APP-Gal4, Gal4-UAS-luciferase (encoding firefly luciferase) were kindly provided from Dr. Thomas Südof, and have been described (Cao and Sudhof, 2001 (link)). The previously reported ubiquilin-1 expressing plasmid was constructed from the pCMV vector and was kindly provided by Dr. Mervyn J. Monteiro (Mah et al., 2000 (link)).
Free full text: Click here